Perhaps the most beautiful aspect of mathematics is that it applies to literally everything, even things that do not exist in ...

Vaccines based on replication-defective adenoviral vectors are being developed for infectious agents and tumor-associated antigens. Early work focused on vaccines derived from a common human serotype ...

In an NBC News story about the reality gap between businesses talking about artificial intelligence (AI) and those that are actually using it, an investment analyst from Oppenheimer said, “There’s not ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...